These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14965296)

  • 21. Computational techniques for diversity analysis and compound classification.
    Kitchen DB; Stahura FL; Bajorath J
    Mini Rev Med Chem; 2004 Dec; 4(10):1029-39. PubMed ID: 15579111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis.
    Bhattacharyya S
    Curr Med Chem; 2001 Oct; 8(12):1383-404. PubMed ID: 11562273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.
    Monge A; Arrault A; Marot C; Morin-Allory L
    Mol Divers; 2006 Aug; 10(3):389-403. PubMed ID: 17031540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse viewpoints on computational aspects of molecular diversity.
    Martin YC
    J Comb Chem; 2001; 3(3):231-50. PubMed ID: 11350246
    [No Abstract]   [Full Text] [Related]  

  • 28. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward automated biochemotype annotation for large compound libraries.
    Chen X; Liang Y; Xu J
    Mol Divers; 2006 Aug; 10(3):495-509. PubMed ID: 16967195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical appraisal of structure-based drug design.
    Tintelnot-Blomley M; Lewis RA
    IDrugs; 2006 Feb; 9(2):114-8. PubMed ID: 16523401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity in medicinal chemistry space.
    Gorse AD
    Curr Top Med Chem; 2006; 6(1):3-18. PubMed ID: 16454754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity.
    Sauer WH; Schwarz MK
    J Chem Inf Comput Sci; 2003; 43(3):987-1003. PubMed ID: 12767158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minor-groove binders.
    Shaikh SA; Ahmed SR; Jayaram B
    Arch Biochem Biophys; 2004 Sep; 429(1):81-99. PubMed ID: 15288812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM.
    Hull RD; Fluder EM; Singh SB; Nachbar RB; Kearsley SK; Sheridan RP
    J Med Chem; 2001 Apr; 44(8):1185-91. PubMed ID: 11312918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical library synthesis using convergent approaches.
    Beeler AB; Schaus SE; Porco JA
    Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces.
    Oprea TI; Gottfries J; Sherbukhin V; Svensson P; Kühler TC
    J Mol Graph Model; 2000; 18(4-5):512-24, 541. PubMed ID: 11143566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The many roles of molecular complexity in drug discovery.
    Méndez-Lucio O; Medina-Franco JL
    Drug Discov Today; 2017 Jan; 22(1):120-126. PubMed ID: 27575998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.